CBDTM Clinical Practice Base of Outdo Biotech in Wuhan Union Hospital officially opened

July 7th, 2021

On the morning of June 28th, 2021, CBDTM Clinical Practice Base of Shanghai National Engineering Research Centre for Biochips in Wuhan Union Hospital officially opened.

Shanghai Outdo Biotech Co.，Ltd（Outdo Biotech ）is a national high-technology enterprises, subordinate to Shanghai Biochip Co., Ltd.(National Engineering Center Biochip at Shanghai), in line with all patient-centered（C） development purposes，focusing on the standardized construction of biobank (B), discipline construction (D), translational research (T) and precision medicine (M). The national center was established in 2001 by the National Development and Reform Commission with an investment of RMB 290 million. It is a representative unit in the field of Omics, high-throughput technique and molecular precision medicine in China, which is the secretariat and chairman of the National Technical Committee 559 on Bio-specimen of Standardization Administration of China(TC559), Biobank Branch of China Medicinal Biotech Association (BBCMBA) and the Integration Research Branch for Cancer Biospecimen of China Anti-Cancer Association.

Wuhan Union Hospital is a large-scale first grade general hospital in Hubei and even in China, with large numbers of autoritive experts and highly valued clinical practice problems advice. It has rich clinical resources, bio samples and strong translational research foundation.

The joint between Outdo Biotech and Wuhan Union Hopital is a milestone for Outdo to strengthen CBTDM mode close cooperation with hospitals, government, research institute, etc. All parties are striving for the biomedical development in China with the hope to benefit human beings all around the world.